- Home
- Products
- Customized FluoroAb™
- CD19
- Taplitumomab paptox-OGreen
Taplitumomab paptox-OGreen (CAT#: ADC-FL-377)
This product is comprised of an anti-CD19 monoclonal antibody (Taplitumomab paptox) labeled with Oregon green. Oregon green is a green-fluorescent dye and it's excitation/emission is 501/526 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Mouse Anti-CD19 IgG1-kappa antibody, Taplitumomab paptox
- Generic name
- Taplitumomab paptox
- Species Reactivity
- Human
- Name
- Oregon green
- Color
- Green
- Excitation⁄Emission (nm)
- 501/526
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-FGFR2 MAb (Clone 13)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4877)
- Anti-TGFB1 MAb (Clone 6)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15346)
- Anti-ICAM1 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8294)
- Anti-ERBB2 MAb (Clone 33)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16285)
- Blinatumomab-OGreen (CAT#: ADC-FL-395)
- Anti-MS4A1 MAb (Clone 22)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2432)
- Anti-IGHE MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS617)
- Toralizumab-OGreen (CAT#: ADC-FL-809)
- Anti-CD40LG MAb (Clone 4)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8491)
- Anti-CEACAM5 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12899)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-377. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
CAT# | Product Name | Linker | Payload |
ADC-W-780 | Anti-CD19 (Blinatumomab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
ADC-W-775 | Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-2520 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-322 | Anti-CD19 (clone hBU12)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-324 | Anti-CD19 (clone huB4)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.